CLINICAL_TRIALS
trial_result
· 2013-11-08
Clinical Trial Update: A Switch Study of BMS-337039 in Schizophrenic Out-patients [Phase 4]
Summary
This entry notes the completion of a Phase 4 switch study of BMS-337039 in outpatients with schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED